Integrated Vaccine and IoT-Blockchain-AI System for Necrotic Enteritis Prevention in Poultry

Publication ID: 24-11857613_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Integrated Vaccine and IoT-Blockchain-AI System for Necrotic Enteritis Prevention in Poultry,” Published Technical Disclosure No. 24-11857613_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857613_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,613.

Summary of the Inventive Concept

A synergistic combination of a plant-based vaccine containing a PlcC-NetB fusion protein with IoT, blockchain, AI, and nanocarrier technologies to prevent necrotic enteritis in poultry, enabling real-time monitoring, secure tracking, and optimized vaccination processes.

Background and Problem Solved

Necrotic enteritis is a significant disease affecting poultry worldwide, causing substantial economic losses. The original patent disclosed a vaccine for prevention of necrotic enteritis in poultry, but it lacked the integration of advanced technologies to enhance its effectiveness. The new inventive concept addresses this limitation by combining the vaccine with IoT, blockchain, AI, and nanocarrier technologies to provide a comprehensive solution for necrotic enteritis prevention.

Detailed Description of the Inventive Concept

The integrated system consists of a plant-based vaccine containing a PlcC-NetB fusion protein, which is administered to poultry to prevent necrotic enteritis. The vaccine is combined with an IoT-enabled monitoring device that tracks poultry health and detects early signs of infection. The vaccination process is secured and tracked using blockchain technology, ensuring transparency and accountability. An AI-powered diagnostic tool is used to identify infected poultry and predict the risk of disease outbreaks. The vaccine is delivered using a nanocarrier system, which targets the gut of the poultry, enhancing its efficacy.

Novelty and Inventive Step

The new claims introduce a synergistic combination of advanced technologies, including IoT, blockchain, AI, and nanocarrier systems, which are not present in the original patent. The integration of these technologies with the vaccine provides a novel and non-obvious solution for necrotic enteritis prevention in poultry.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different types of vaccines, such as mRNA-based vaccines, or the integration of other advanced technologies, such as robotics or machine learning algorithms, to enhance the system's effectiveness. Variations of the system may be designed for use in different poultry production settings, such as large-scale industrial farms or small-scale backyard farms.

Potential Commercial Applications and Market

The integrated vaccine and IoT-blockchain-AI system has significant commercial potential in the poultry industry, which is a multi-billion-dollar market. The system can be marketed to poultry producers, veterinarians, and animal health companies, offering a comprehensive solution for necrotic enteritis prevention and enhancing animal welfare.

CPC Classifications

SectionClassGroup
A A61 A61K39/08
A A61 A61P31/04
C C12 C12N15/74
C C12 C12N15/8258
A A61 A61K2039/552
A A61 A61K2039/55577

Original Patent Information

Patent NumberUS 11,857,613
TitleVaccine for prevention of necrotic enteritis in poultry
Assignee(s)Arizona Board of Regents on Behalf of Arizona State University